Image Image Image Image Image Image Image Image Image Image
Accesibilidad
Ir arriba

Arriba

Foto44_3

· 20/12/2014

MPL4 GA: Estudio Fase I en pacientes con atrofia geográfica secundaria a DMAE atrófica

Foto49_3

· 20/12/2014

Oral Omega 3 GA. Estudio Fase II para pacientes con atrofia geográfica secundaria a DMAE

Queratitis

· 02/07/2014

Estudio M-13-027: Evaluation of Clinical Outcomes Following Treatment with Systane® Balance in Dry Eye Subjects with Lipid Deficiency

Glaucoma_Nervioptic1_PORTADA

· 02/07/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma

Traccio macular

· 02/07/2014

JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion

Foto3

· 19/03/2014

TREND: Estudio fase IIIb multicentrico, randomizado, de 12 meses de seguimiento con evaluador de la agudeza visual enmascarado, para evaluar la eficacia y la seguridad de ranibizumab 0,5mg en un régimen de tratar y extender comparado con un régimen mensual, en pacientes con degeneración macular neovascular asociada a la edad

Foto1_def2

· 19/03/2014

MACBETH. Ensayo clínico en fase IV para evaluar la eficacia de aflibercept en pacientes con degeneración macular asociada a la edad (DMAE) neovascular, sin respuesta óptima a repetidas inyecciones mensuales intravitreas de anti VEGF-A

Foto51_2

· 26/03/2013

GAIN. Characterization of geographic atrophy progression in patients with age-related macular degeneration: evolution and risk factors associated with geographic atrophy progression

Foto49_3

· 26/03/2013

Oral Omega 3 Drusen: A phase II randomized, double-mask study to establish the safety and efficacy of High-Dose Oral Omega 3 in subjects with high-risk drusen secondary to dry age-related macular degeneration 

Foto46-2

· 26/03/2013

The Brighter Study: a 24-month, phase IIIB, open-label, randomized, active controlled, three-arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven pro re nata dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy or with adjunctive laser photocoagulation in comparison to laser photocoagulation in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO)

Foto46_3

· 26/03/2013

The Crystal Study: a 24-month, phase IIIB, open-label, single arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven pro re nata dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO)

Foto45_2

· 26/03/2013

MPL4 DRUSEN. A phase I study to establish the safety and efficacy of retinal pigment epithelium micropulse laser in subjects with high-risk drusen secondary to age-related macular degeneration 

Foto43_1

· 26/03/2013

Translational research in regenerative stem cell therapies for retinal degenerative diseases: from the swine animal model of retinal atrophy to clinical trials in human patients with age-related macular degeneration, retinitis pigmentosa and Stargardt’s disease

Foto42_3

· 26/03/2013

GAP. A phase I escalating dose of subretinal sodium iodate: a toxi-induced animal model of geography atrophy of RPE and phtotoreceptors

_MG_7643

· 26/03/2013

Pilot phase II clinical trial to evalute safety of human fetal retinal transplant in the treatment of geographic atrophy secondary to age-related macular degeneration and retinitis pigmentosa

Última modificación: 21 Julio, 2019 - 21:34